title: Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases.
abstract: Diagnosis of Hodgkin's disease (HD) is quite difficult in the patient with seropositivity for human T cell lymphotropic virus I (HTLV-I). Herein, two cases of Epstein-Barr virus (EBV)-associated HD, which occurred in males with seropositivity for anti-HTLV-I, are reported. One patient is alive and was diagnosed as having interfollicular HD with CD20+CD15-CD30-CD3-CD4-CD8-CD45RO-Read-Sternberg (R-S) cells. Positivity for EBV-encoded RNA 1 (EBER-1) and latent membrane protein 1 (LMP-1) was shown on follicular germinal center cells and R-S cells. In that case, neither T cell receptor (TCR) beta chain rearrangement nor integration of the HTLV-I provirus was demonstrated in the lymph nodes, although atyical lymphocytes (2%) were found in the peripheral blood. The other case pursued an aggressive clinical course and the patient was diagnosed as having an adult T cell leukemia/lymphoma (ATLL) because of the presence of anti-HTLV-I antibody, lymph node swelling, and the appearance of flower-like cells in the peripheral blood. However, an autopsy revealed no obvious ATLL cell infiltration in any of the organs examined. Multiple granulomatous lesions were found in the bone marrow, liver, kidneys, spleen, and lymph nodes. Reassessment of lymph node lesions in biopsies and granulomatous lesions in autopsy samples demonstrated that both lesions contained CD15+CD30+CD3-CD4-CD8-CD20-CD45RO-EBER-1+L MP-1+R-S cells, and they were considered to be a composite lymphoma of HD and ATLL. These two cases therefore suggest that EBV-associated HD can develop in patients with seropositivity for HTLV-I.
authors.affiliation: Department of Pathology, Kawasaki Medical School, Kurashiki, Japan. sadapath@med.kawasaki-m.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Sadahira
authors.forename: H
authors.initials: H
authors.lastname: Nishihara
authors.forename: M
authors.initials: M
authors.lastname: Shimizu
authors.forename: M
authors.initials: M
authors.lastname: Hirokawa
authors.forename: H
authors.initials: H
authors.lastname: Wada
authors.forename: O
authors.initials: O
authors.lastname: Yamada
authors.forename: Y
authors.initials: Y
authors.lastname: Yawata
authors.forename: T
authors.initials: T
authors.lastname: Manabe
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D017809:Fatal Outcome; D015490:HTLV-I Infections / Q000150:complications* / Q000378:metabolism / Q000473:pathology* / Q000821:virology; D006566:Herpesviridae Infections / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000821:virology; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006689:Hodgkin Disease / Q000150:complications / Q000378:metabolism / Q000473:pathology* / Q000821:virology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D016256:Lewis X Antigen / Q000378:metabolism; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology / Q000821:virology; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000378:metabolism; D016539:Reed-Sternberg Cells / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D014412:Tumor Virus Infections / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000821:virology
chemical_list: D015703:Antigens, CD; C099537:Epstein-Barr virus encoded RNA 1; D016256:Lewis X Antigen; D012367:RNA, Viral